Sapporo Medical University Hospital
Sapporo, Hokkaido, Japan
University hospital in Sapporo
16 Chome-291 Minami 1 Jonishi, Chuo Ward, Sapporo, Hokkaido 060-8543
About Sapporo Medical University Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
5
Shire
5
Janssen Research & Development, LLC
4
Actelion
3
Eli Lilly and Company
3
Haruhiko Fukuda
3
Hoffmann-La Roche
3
Janssen Pharmaceutical K.K.
3
Pfizer
3
Takeda
3
Amgen
2
Clinical Trials at Sapporo Medical University Hospital
During the past decade, Sapporo Medical University Hospital conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 21 clinical trials were completed, i.e. on
average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 14 clinical trials were completed. i.e. 73.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy
2004-05-01
2016-05-01
Completed
200
A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease
2005-07-01
2012-08-01
Completed
6
A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)
2004-07-01
2011-11-01
Completed
167
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
2006-03-01
2010-10-01
Completed
628
Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)
2006-02-01
2011-11-01
Completed
253
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
2008-03-01
2011-06-01
Completed
300
Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
2009-08-01
2016-02-01
Completed
213
Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery With Epidural Anesthesia or Spinal Anesthesia Without Intubation
2011-06-03
2011-11-18
Completed
119
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sapporo Medical University Hospital" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Shire" with 5 trials
sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Actelion" with 3 trials sponsored and "Eli Lilly and Company"
with 3 trials sponsored. Other sponsors include 44 different institutions and
companies that sponsored additional 36 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sapporo Medical University Hospital"
#1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 3 trials as a collaborator, "Chugai Pharmaceutical" with 2 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were
collaborators in the rest 25 trials.
Clinical Trials Conditions at Sapporo Medical University Hospital
According to Clinical.Site data, the most researched conditions in "Sapporo Medical University Hospital" are
"Crohn's Disease" (6 trials), "Ulcerative Colitis" (5 trials), "Carcinoma, Renal Cell" (3 trials), "Lung Diseases, Interstitial" (3 trials) and "Colitis, Ulcerative" (2 trials). Many other conditions were trialed in "Sapporo Medical University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Sapporo Medical University Hospital
Most popular intervention types in "Sapporo Medical University Hospital" are "Drug" (60 trials), "Other" (10 trials), "Biological" (5 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (25 trials), "Nintedanib" (4 trials), "Ontamalimab" (4 trials), "Pembrolizumab" (3 trials) and "Ustekinumab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Sapporo Medical University Hospital
The vast majority of trials in "Sapporo Medical University Hospital" are
61 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Sapporo Medical University Hospital
Currently, there are NaN active trials in "Sapporo Medical University Hospital".
undefined are not yet recruiting,
13 are recruiting,
15 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 30 completed trials in Sapporo Medical University Hospital,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Sapporo Medical University Hospital, 2 "Phase 1"
clinical trials were conducted, 19 "Phase 2" clinical
trials and 44 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".